| dc.contributor |
University of Aberdeen.Rowett Institute |
|
| dc.contributor |
University of Aberdeen.Clinical Medicine |
|
| dc.contributor |
University of Aberdeen.Medical Sciences - Cardiovascular Group |
|
| dc.creator |
Turck, Dominique |
|
| dc.creator |
Castenmiller, Jacqueline |
|
| dc.creator |
De Henauw, Stefaan |
|
| dc.creator |
Hirsch-Ernst, Karen Ildico |
|
| dc.creator |
Kearney, John |
|
| dc.creator |
Knutsen, Helle Katrine |
|
| dc.creator |
Maciuk, Alexandre |
|
| dc.creator |
Mangelsdorf, Inge |
|
| dc.creator |
McArdle, Harry J |
|
| dc.creator |
Naska, Androniki |
|
| dc.creator |
Pelaez, Carmen |
|
| dc.creator |
Pentieva, Kristina |
|
| dc.creator |
Thies, Frank |
|
| dc.creator |
Tsabouri, Sophia |
|
| dc.creator |
Vinceti, Marco |
|
| dc.creator |
Bresson, Jean-Louis |
|
| dc.creator |
Siani, Alfonso |
|
| dc.creator |
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) |
|
| dc.date |
2021-05-29T20:29:01Z |
|
| dc.date |
2021-05-29T20:29:01Z |
|
| dc.date |
2020-10-22 |
|
| dc.date.accessioned |
2022-05-24T06:09:53Z |
|
| dc.date.available |
2022-05-24T06:09:53Z |
|
| dc.identifier |
Turck , D , Castenmiller , J , De Henauw , S , Hirsch-Ernst , K I , Kearney , J , Knutsen , H K , Maciuk , A , Mangelsdorf , I , McArdle , H J , Naska , A , Pelaez , C , Pentieva , K , Thies , F , Tsabouri , S , Vinceti , M , Bresson , J-L , Siani , A & EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) 2020 , ' Anxiofit-1 and reduction of subthreshold and mild anxiety : evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 ' , EFSA Journal , vol. 18 , no. 10 , e06264 . https://doi.org/10.2903/j.efsa.2020.6264 |
|
| dc.identifier |
1831-4732 |
|
| dc.identifier |
PURE: 191209550 |
|
| dc.identifier |
PURE UUID: d04fe6dc-7c80-4afe-9686-ab51c2eca27c |
|
| dc.identifier |
PubMed: 33117457 |
|
| dc.identifier |
PubMedCentral: PMC7579687 |
|
| dc.identifier |
Scopus: 85094910847 |
|
| dc.identifier |
ORCID: /0000-0002-9275-9713/work/99981906 |
|
| dc.identifier |
https://hdl.handle.net/2164/16574 |
|
| dc.identifier |
https://doi.org/10.2903/j.efsa.2020.6264 |
|
| dc.identifier |
18 |
|
| dc.identifier |
10 |
|
| dc.identifier.uri |
http://localhost:8080/xmlui/handle/CUHPOERS/117868 |
|
| dc.description |
Acknowledgements: EFSA wishes to acknowledge the contribution of WG on Claims: Jean‐Louis Bresson, Stefaan de Henauw, Alfonso Siani and Frank Thies to this opinion. Requestor: Competent Authority of Hungary following an application by Anxiofit Ltd. Question number: EFSA‐Q‐2020‐00032 |
|
| dc.description |
Peer reviewed |
|
| dc.description |
Publisher PDF |
|
| dc.format |
11 |
|
| dc.format |
application/pdf |
|
| dc.language |
eng |
|
| dc.relation |
EFSA Journal |
|
| dc.rights |
This is an open access article under the terms of the Creative Commons Attribution-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited and no modifications or adaptations are made. https://creativecommons.org/licenses/by-nc/4.0/ |
|
| dc.subject |
SDG 3 - Good Health and Well-being |
|
| dc.subject |
Anxiofit-1 |
|
| dc.subject |
Echinacea angustifolia |
|
| dc.subject |
anxiety |
|
| dc.subject |
health claim |
|
| dc.subject |
R Medicine |
|
| dc.subject |
R |
|
| dc.title |
Anxiofit-1 and reduction of subthreshold and mild anxiety : evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 |
|
| dc.type |
Journal article |
|